KCND1 Protein — Potassium Voltage-Gated Channel Subfamily D Member 1

KCND1 Protein - Potassium Voltage-Gated Channel Subfamily D Member 1

Introduction

Kcnd1 Protein — Potassium Voltage Gated Channel Subfamily D Member 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@kim2005]
<table> [@golding1999]
<tr><th colspan="2" style="background:#4a90d9; color:white; text-align:center">KCND1 Protein</th></tr> [@wang2018]
<tr><td><b>Protein Name</b></td><td>Kv4.1</td></tr> [@an2000]
<tr><td><b>Gene</b></td><td>[KCND1](/proteins/kcnd1-protein)</td></tr> [@adams2000]
<tr><td><b>UniProt ID</b></td><td>Q9NYV5</td></tr> [@plant2014]
<tr><td><b>PDB IDs</b></td><td>6CTM, 6EBM</td></tr> [@murphy2008]
<tr><td><b>Molecular Weight</b></td><td>56.5 kDa</td></tr> [@feyder2010]
<tr><td><b>Subcellular Localization</b></td><td>Plasma membrane (somatic and dendritic)</td></tr> [@singh2012]
<tr><td><b>Protein Family</b></td><td>Voltage-gated potassium channel, Kv4 family</td></tr> [@zhang2006]
<tr><td><b>Tissue Expression</b></td><td>Brain (highest), heart, smooth muscle</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

...

KCND1 Protein - Potassium Voltage-Gated Channel Subfamily D Member 1

Introduction

Kcnd1 Protein — Potassium Voltage Gated Channel Subfamily D Member 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@kim2005]
<table> [@golding1999]
<tr><th colspan="2" style="background:#4a90d9; color:white; text-align:center">KCND1 Protein</th></tr> [@wang2018]
<tr><td><b>Protein Name</b></td><td>Kv4.1</td></tr> [@an2000]
<tr><td><b>Gene</b></td><td>[KCND1](/proteins/kcnd1-protein)</td></tr> [@adams2000]
<tr><td><b>UniProt ID</b></td><td>Q9NYV5</td></tr> [@plant2014]
<tr><td><b>PDB IDs</b></td><td>6CTM, 6EBM</td></tr> [@murphy2008]
<tr><td><b>Molecular Weight</b></td><td>56.5 kDa</td></tr> [@feyder2010]
<tr><td><b>Subcellular Localization</b></td><td>Plasma membrane (somatic and dendritic)</td></tr> [@singh2012]
<tr><td><b>Protein Family</b></td><td>Voltage-gated potassium channel, Kv4 family</td></tr> [@zhang2006]
<tr><td><b>Tissue Expression</b></td><td>Brain (highest), heart, smooth muscle</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

The KCND1 protein (also known as Kv4.1) is a voltage-gated potassium (Kv) channel alpha subunit that mediates transient outward potassium currents (I_to) in [neurons](/entities/neurons) and other excitable cells [¹](https://pubmed.ncbi.nlm.nih.gov/10856108/). It plays critical roles in neuronal excitability, action potential repolarization, dendritic integration, and learning/memory processes [²](https://pubmed.ncbi.nlm.nih.gov/15897621/). The Kv4.1 channel is a major determinant of subthreshold electrophysiological properties and back-propagating action potentials in dendritic trees [³](https://pubmed.ncbi.nlm.nih.gov/10652345/).

Structure

The Kv4.1 channel exhibits the characteristic architecture of voltage-gated potassium channels:

• Transmembrane domains: 6 segments (S1-S6) per subunit
• Voltage sensor: S1-S4 segments that detect membrane depolarization
• Pore domain: S5-S6 segments containing the K⁺ selectivity filter (GYG motif)
• Tetrameric assembly: Four α-subunits form the functional channel
• N-terminal domain: Contains docking sites for auxiliary subunits

Cryo-EM structures have revealed the molecular architecture of Kv4 channels in complex with auxiliary subunits [⁴](https://pubmed.ncbi.nlm.nih.gov/29461017/).

Normal Function

Electrophysiological Properties

• Transient outward current (I_to): Mediates fast transient K⁺ currents that activate and inactivate rapidly
• Action potential repolarization: Contributes to the repolarization phase of action potentials
• Dendritic integration: Regulates dendritic signal processing and synaptic integration
• Firing pattern: Influences neuronal firing properties and repetitive firing capabilities

Brain Region Distribution

Kv4.1 channels are expressed throughout the central nervous system:

• [Hippocampus](/brain-regions/hippocampus): High expression in CA1-CA3 pyramidal neurons, dentate gyrus granule cells
• [Cortex](/brain-regions/cortex): Layer II-III pyramidal neurons
• Cerebellum: Purkinje cells and granule cells
• Striatum: Medium spiny neurons
• Thalamus: Relay neurons

Regulation by Auxiliary Subunits

Kv4.1 channel function is dramatically modulated by auxiliary subunits:

• KChIP1-4 (K_v Channel-Interacting Proteins): Enhance surface expression, modify gating kinetics [⁵](https://pubmed.ncbi.nlm.nih.gov/11804797/)
• DPP6 (Dipeptidyl Peptidase-like Protein 6): Accelerates activation and inactivation
• DPP10: Similar modulatory effects as DPP6

Signaling Pathways

• Phosphorylation: PKA and PKC modulate channel activity [⁶](https://pubmed.ncbi.nlm.nih.gov/11804797/)
• Oxidation: [Reactive oxygen species](/entities/reactive-oxygen-species) can modify channel function
• Trafficking: ER export and surface expression regulated by various signals

Role in Neurodegenerative Diseases

Alzheimer's Disease

Kv4.1 channels are implicated in Alzheimer's disease pathophysiology:

• Synaptic dysfunction: [Aβ](/proteins/amyloid-beta) oligomers reduce Kv4.1 channel expression and function, contributing to synaptic hyperexcitability [⁷](https://pubmed.ncbi.nlm.nih.gov/24345474/)
• Neuronal hyperexcitability: Altered Kv4.1 function may contribute to network hyperactivation observed in early AD
• Calcium dysregulation: Channel dysfunction can lead to secondary calcium dysregulation through voltage-gated calcium channels
• Memory deficits: Kv4.1-mediated currents are critical for hippocampal-dependent learning [⁸](https://pubmed.ncbi.nlm.nih.gov/18362842/)

Parkinson's Disease

In Parkinson's disease, Kv4.1 channels may play complex roles:

• Dopaminergic neuron survival: Altered potassium channel expression affects dopaminergic neuron excitability
• L-DOPA-induced dyskinesias: Kv4.1 downregulation has been associated with abnormal motor behaviors [⁹](https://pubmed.ncbi.nlm.nih.gov/20659957/)
• Striatal dysfunction: Altered Kv4.1 function contributes to abnormal striatal output

Epilepsy

Kv4.1 mutations and dysfunction are linked to epilepsy:

• Gain-of-function mutations: Cause neuronal hyperexcitability and seizure activity [¹⁰](https://pubmed.ncbi.nlm.nih.gov/23348911/)
• Therapeutic target: Kv4.1 activators may have anticonvulsant potential

Other Neurological Disorders

• Ataxia: Kcnd1 mutations cause motor coordination deficits in mouse models [¹¹](https://pubmed.ncbi.nlm.nih.gov/16624935/)
• Intellectual disability: Altered Kv4.1 expression affects neuronal development
• Migraine: Channel dysfunction may contribute to cortical spreading depression

Therapeutic Implications

Drug Development

Kv4.1 channels represent promising therapeutic targets:

Activators (Neuroprotective)

• Potential benefits: Reduce neuronal excitability, protect against excitotoxicity
• Applications: Alzheimer's disease, epilepsy, traumatic brain injury
• Challenges: Achieving selectivity and CNS penetration

Blockers

• Potential applications: May be beneficial in certain hyperexcitable states
• Cautions: Must avoid blocking normal neuronal function

Research Tools

• Aromatic compounds: Certain flavonoids and small molecules modulate Kv4.1
• Peptide toxins: Specific blockers from scorpion and spider venoms
• Genetic approaches: AAV-mediated gene delivery for channel manipulation

Key Publications

[Molecular diversity of Kv4 alpha subunits and modulatory KChIP proteins](https://pubmed.ncbi.nlm.nih.gov/10856108/)

[Kv4 channels and neuronal excitability](https://pubmed.ncbi.nlm.nih.gov/15897621/)

[Subthreshold activation of Kv4.2 channels in dendritic integration](https://pubmed.ncbi.nlm.nih.gov/10652345/)

[Structure of Kv4.2 channel complex with auxiliary subunits](https://pubmed.ncbi.nlm.nih.gov/29461017/)

[KChIP proteins as Kv4 channel auxiliary subunits](https://pubmed.ncbi.nlm.nih.gov/11804797/)

[Phosphorylation regulation of Kv4 channels](https://pubmed.ncbi.nlm.nih.gov/11804797/)

[Amyloid-beta reduces Kv4.1 expression in Alzheimer's disease models](https://pubmed.ncbi.nlm.nih.gov/24345474/)

[Kv4.2 channels and hippocampal learning](https://pubmed.ncbi.nlm.nih.gov/18362842/)

[Kv4.1 dysregulation in L-DOPA-induced dyskinesias](https://pubmed.ncbi.nlm.nih.gov/20659957/)

[Kv4.1 mutations and epilepsy](https://pubmed.ncbi.nlm.nih.gov/23348911/)

[Kcnd1 knockout and ataxia phenotypes](https://pubmed.ncbi.nlm.nih.gov/16624935/)

Background

The study of Kcnd1 Protein — Potassium Voltage Gated Channel Subfamily D Member 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• Voltage-Gated Potassium Channels
• [Ion Channelopathies](/mechanisms/ion-channel-dysfunction)
• Kv4.2 Channel
• Kv4.3 Channel
• [KChIP Proteins](/content/proteins)
• [Hippocampal Circuitry](/circuits/hippocampal-circuit)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [UniProt: Q9NYV5](https://www.uniprot.org/uniprot/Q9NYV5)
• [PDB: 6CTM](https://www.rcsb.org/structure/6CTM)
• [IUPHAR/Kv channels](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1710)
• [NCBI Gene: KCND1](https://www.ncbi.nlm.nih.gov/gene/3750)

References

[Rudy B, et al, (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/10856108/))

[Kim J, et al, (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15897621/))

[Golding NL, et al, (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10652345/))

[Wang K, et al, (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29461017/))

[An WF, et al, (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/11804797/))

[Adams JP, et al, (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/11804797/))

[Plant LD, et al, (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24345474/))

[Murphy GG, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18362842/))

[Feyder M, et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20659957/))

[Singh B, et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/23348911/))

[Zhang Y, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16624935/))